Skip to main content

Tris Pharma recalls infant ibuprofen for being too strong, risking permanent renal injury

Tris Pharma says it is voluntarily recalling some lots of infant ibuprofen for being too strong, and putting users at risk of being vulnerable to permanent renal injury.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.